Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Last Close
Feb 10  •  04:00PM ET
75.70
Dollar change
-0.07
Percentage change
-0.09
%
IndexS&P 500 P/E54.89 EPS (ttm)1.38 Insider Own0.14% Shs Outstand1.27B Perf Week-1.47%
Market Cap96.10B Forward P/E9.21 EPS next Y8.22 Insider Trans-0.41% Shs Float1.27B Perf Month-5.73%
Enterprise Value165.62B PEG0.74 EPS next Q2.23 Inst Own89.64% Short Float1.61% Perf Quarter-4.17%
Income1.77B P/S0.24 EPS this Y6.17% Inst Trans2.12% Short Ratio2.48 Perf Half Y16.68%
Sales402.13B P/B1.28 EPS next Y14.70% ROA0.69% Short Interest20.35M Perf YTD-4.61%
Book/sh59.18 P/C9.07 EPS next 5Y12.37% ROE2.35% 52W High85.15 -11.10% Perf Year39.44%
Cash/sh8.35 P/FCF12.31 EPS past 3/5Y-24.72% -23.95% ROIC1.18% 52W Low53.36 41.87% Perf 3Y-15.57%
Dividend Est.2.80 (3.69%) EV/EBITDA10.40 Sales past 3/5Y7.60% 8.40% Gross Margin13.62% Volatility4.30% 3.34% Perf 5Y2.53%
Dividend TTM2.66 (3.51%) EV/Sales0.41 EPS Y/Y TTM-61.77% Oper. Margin3.10% ATR (14)2.71 Perf 10Y-18.70%
Dividend Ex-DateJan 22, 2026 Quick Ratio0.63 Sales Y/Y TTM7.90% Profit Margin0.44% RSI (14)44.76 Recom1.63
Dividend Gr. 3/5Y9.07% 5.87% Current Ratio0.84 EPS Q/Q76.42% SMA20-2.93% Beta0.50 Target Price95.09
Payout191.37% Debt/Eq1.06 Sales Q/Q8.40% SMA50-3.60% Rel Volume1.60 Prev Close75.77
Employees300000 LT Debt/Eq0.99 EarningsFeb 10 BMO SMA2004.59% Avg Volume8.21M Price75.70
IPOOct 01, 1952 Option/ShortYes / Yes EPS/Sales Surpr.8.73% 1.95% Trades Volume13,099,893 Change-0.09%
Date Action Analyst Rating Change Price Target Change
Oct-14-25Initiated Goldman Buy $91
Aug-18-25Upgrade UBS Neutral → Buy $79
Aug-14-25Upgrade Robert W. Baird Neutral → Outperform $82
Feb-13-25Upgrade Leerink Partners Market Perform → Outperform $55 → $75
Feb-12-25Upgrade Cantor Fitzgerald Neutral → Overweight
Jan-30-25Upgrade Edward Jones Hold → Buy
Dec-03-24Upgrade Deutsche Bank Hold → Buy $66
Nov-18-24Upgrade Wells Fargo Equal Weight → Overweight $60 → $66
Oct-10-24Upgrade Barclays Equal Weight → Overweight $63 → $82
Oct-04-24Upgrade TD Cowen Hold → Buy $59 → $85
Feb-10-26 10:07PM
05:15PM
04:24PM
04:23PM
04:11PM
04:03PM Loading…
04:03PM
03:43PM
02:13PM
02:02PM
12:53PM
11:43AM
10:59AM
10:58AM
10:04AM
09:47AM
09:47AM Loading…
09:47AM
09:34AM
09:34AM
09:34AM
09:30AM
08:50AM
08:35AM
08:15AM
07:40AM
07:24AM
07:19AM
07:12AM
06:53AM
06:48AM
06:42AM
06:41AM Loading…
06:41AM
06:37AM
06:34AM
06:30AM
06:00AM
04:27AM
Feb-09-26 07:55PM
11:30AM
08:26AM
06:23AM
Feb-08-26 10:05PM
02:00PM
Feb-06-26 08:37PM
04:08PM
01:52PM
Feb-05-26 04:00PM
12:49PM
12:48PM
11:13AM
09:15AM
08:01AM
08:00AM
07:00AM
Feb-04-26 05:45PM
01:15PM
11:30AM
08:47AM
06:46AM
Feb-03-26 04:49PM
10:00AM
07:55AM
03:08AM
Feb-02-26 07:15AM
05:47AM
Feb-01-26 05:30PM
Jan-31-26 09:35AM
07:47AM
Jan-30-26 02:23PM
09:40AM
Jan-29-26 10:38AM
09:13AM
02:19AM
Jan-28-26 05:45PM
12:35PM
12:24PM
12:07PM
07:42AM
05:30AM
03:20AM
Jan-27-26 11:31PM
07:13PM
07:06PM
05:34PM
05:33PM
05:12PM
04:54PM
04:44PM
04:44PM
04:41PM
04:38PM
04:37PM
04:17PM
04:15PM
04:13PM
03:27PM
03:19PM
03:17PM
03:11PM
02:51PM
02:36PM
CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations. The Corporate and Other Segment is involved in management and administrative expenses. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Finucane Anne A.DirectorAug 20 '25Sale71.027,500532,65022,156Aug 29 04:29 PM
Finucane Anne A.DirectorAug 20 '25Proposed Sale70.977,500532,275Aug 19 06:57 PM
SANSONE GUY PDirectorJun 05 '25Buy63.701,570100,00912,007Jun 09 08:22 AM
ROBBINS LARRYDirectorMay 02 '25Sale67.862,276,068154,444,7589,670,731May 06 04:15 PM
ROBBINS LARRYDirectorMay 05 '25Sale67.411,323,93289,249,9458,346,799May 06 04:15 PM
ROBBINS LARRYDirectorMay 06 '25Sale66.67150,00010,000,7108,196,799May 06 04:15 PM
Shah Prem SEVP and Group PresidentMar 17 '25Option Exercise62.2184652,63043,190Mar 18 04:51 PM
Clark James DavidSVP, Cont & Chief Acct OfficerMar 05 '25Option Exercise62.217,513467,38415,907Mar 07 04:56 PM
Clark James DavidSVP, Cont & Chief Acct OfficerMar 05 '25Sale66.357,513498,4888,394Mar 07 04:56 PM
Clark James DavidOfficerMar 05 '25Proposed Sale66.357,513498,489Mar 05 05:25 PM
Mahoney Michael FDirectorFeb 18 '25Buy66.7030,0002,001,00039,356Feb 19 12:35 PM